Suppr超能文献

心脏和胸腔积液中的转移性涎腺导管癌:一例报告及雄激素受体和HER2的免疫细胞化学分析

Metastatic salivary duct carcinoma in cardiac and pleural effusions: A case report with immunocytochemical analysis for androgen receptor and HER2.

作者信息

Ito Hiroko, Ishida Mitsuaki, Sando Kaori, Okano Kimiaki, Ebisu Yusuke, Fujisawa Takuo, Iwai Hiroshi, Tsuta Koji

机构信息

Department of Pathology and Laboratory Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.

Department of Otolaryngology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.

出版信息

Mol Clin Oncol. 2019 Jan;10(1):78-82. doi: 10.3892/mco.2018.1747. Epub 2018 Oct 17.

Abstract

Salivary duct carcinoma (SDC) is a relatively rare highly aggressive salivary gland tumor. Although SDC shows frequent lymph node and distant metastases, the presence of neoplastic cells in the pleural effusion is extremely rare. In this report, we describe the first documented cytological case of metastatic SDC in cardiac and pleural effusions with immunocytochemical analyses for androgen receptor (AR) and human epidermal growth factor receptor (HER)2. A 52-year-old Japanese male developed cardiac tamponade and respiratory discomfort after surgery and chemo-radiation therapy for SDC of the right submandibular gland. Aspiration of the cardiac and pleural effusions was performed. The Papanicolaou-stained cytological specimens of cardiac and pleural effusions showed that numerous small ball-like or papillary structures were present in an inflammatory background. The neoplastic cells had rich granular cytoplasm and large round to oval nuclei containing conspicuous nucleoli. Immunocytochemical analyses clearly demonstrated positivity for AR and strong membranous expression of HER2 in the neoplastic cells. Accordingly, a cytodiagnosis of metastatic SDC was made. Recently, HER2-targeted or AR deprivation therapy have been introduced for patients with SDC, therefore, determination of expression profiles of AR and HER2 may be crucial for developing a treatment strategy for patients with metastatic SDC. According to the results of the present report, immunocytochemical analyses for AR and HER2 in the effusion specimens may be useful for determination of a treatment strategy for patients with metastatic SDC.

摘要

涎腺导管癌(SDC)是一种相对罕见但侵袭性很强的涎腺肿瘤。尽管SDC常发生淋巴结转移和远处转移,但肿瘤细胞出现在胸腔积液中极为罕见。在本报告中,我们描述了首例经记录的心脏和胸腔积液中转移性SDC的细胞学病例,并对雄激素受体(AR)和人表皮生长因子受体(HER)2进行了免疫细胞化学分析。一名52岁的日本男性在接受右下颌下腺SDC手术及放化疗后出现心脏压塞和呼吸不适。对心脏和胸腔积液进行了抽吸。心脏和胸腔积液的巴氏染色细胞学标本显示,在炎症背景中有许多小球状或乳头状结构。肿瘤细胞具有丰富的颗粒状细胞质,细胞核大,呈圆形至椭圆形,有明显的核仁。免疫细胞化学分析清楚地表明肿瘤细胞中AR呈阳性,HER2呈强膜表达。因此,作出了转移性SDC的细胞诊断。最近,针对SDC患者引入了HER2靶向治疗或雄激素剥夺治疗,因此,确定AR和HER2的表达谱对于制定转移性SDC患者的治疗策略可能至关重要。根据本报告的结果,对积液标本进行AR和HER2的免疫细胞化学分析可能有助于确定转移性SDC患者的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f80b/6313956/7482e72bacc4/mco-10-01-0078-g00.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验